Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 208, Issue 9, Pages 1799-1807
Publisher
Rockefeller University Press
Online
2011-08-23
DOI
10.1084/jem.20110846
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pim kinase inhibitors: a survey of the patent literature
- (2010) Tina Morwick EXPERT OPINION ON THERAPEUTIC PATENTS
- Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
- (2010) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia
- (2010) Konstantinos J. Mavrakis et al. NATURE CELL BIOLOGY
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
- (2009) L. S. Chen et al. BLOOD
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
- (2009) Nahum Sonenberg et al. CELL
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
- (2009) Georg Hess et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Evaluating Temsirolimus Activity in Multiple Tumors: A Review of Clinical Trials
- (2009) Janet E. Dancey et al. SEMINARS IN ONCOLOGY
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- Tumorigenic activity and therapeutic inhibition of Rheb GTPase
- (2008) K. J. Mavrakis et al. GENES & DEVELOPMENT
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
- (2008) Eric D. Hsi et al. LEUKEMIA & LYMPHOMA
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTORC1 promotes survival through translational control of Mcl-1
- (2008) J. R. Mills et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs
- (2008) L. Rong et al. RNA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started